A standardized, better-absorbed citrus extract of hesperidin, a natural plant compound from oranges, taken to support blood vessels and the heart. The most dependable signal is a small lowering of blood fats and inflammation markers. Effects on vessel widening, blood pressure, and blood sugar are inconsistent. Safety is reassuring; evidence rests on short trials and lab markers, not long-term outcomes. (Full Review)

Protocol

Standard Dose

500 mg once daily

Standardized extract; the dose with the most supporting human data for vascular and inflammation markers.

Form Selection

2S-diastereoisomer, micronized

High-bioavailability form underlying Cordiart; aims to overcome the erratic absorption of ordinary hesperidin.

Best Time of Day

With a meal

Supports absorption and may reduce digestive complaints; consistency of timing matters more than the specific hour.

Time to effect

Lipids

12+ weeks

Lipid changes were clearer at 12 weeks or longer.

Vascular & Inflammation Markers

~3 weeks

Markers shifted within about 3 weeks in the metabolic-syndrome study. Benefits are gradual, not acute.

Benefits

Medium: Improved blood lipid profile; reduced vascular inflammation markers

Low: Improved endothelial function; lower systolic blood pressure; modest glycemic and metabolic improvements

Speculative: Support for healthy aging via reduced vascular inflammation; cognitive and cerebral blood flow benefits

Contraindications

Pregnant or breastfeeding individuals (insufficient safety data)

People with bleeding disorders or scheduled for surgery within roughly 2 weeks

Individuals on multiple blood-pressure or blood-thinning agents without clinician oversight

Key Interactions

Anticoagulant and antiplatelet drugs (warfarin, apixaban, rivaroxaban, aspirin, clopidogrel)

Antihypertensive drugs (ACE inhibitors such as lisinopril, calcium channel blockers such as amlodipine)

Lipid-lowering and glucose-lowering drugs (statins, metformin)

Over-the-counter antiplatelet agents (aspirin) and NSAIDs (ibuprofen, naproxen)

Blood-pressure-lowering or blood-thinning supplements (omega-3 fish oil, garlic, Ginkgo biloba, nattokinase, L-citrulline, beetroot/nitrate)

Substrates of P-glycoprotein or affected phase-II enzymes

Risk & Side Effects

Low: Gastrointestinal discomfort; modest weight increase

Speculative: Bleeding risk with anticoagulants; drug-metabolizing enzyme and transporter effects; pregnancy and lactation safety

Monitoring

Marker	Target	Why
LDL cholesterol	< 100 mg/dL (often < 70 mg/dL for high-risk)	Primary lipid target hesperidin may lower
Triglycerides	< 100 mg/dL	Responsive lipid marker
Total cholesterol	< 180 mg/dL	Broad lipid overview
High-sensitivity C-reactive protein (hs-CRP)	< 1.0 mg/L	Tracks vascular inflammation, a key proposed effect
Fasting blood glucose	70–85 mg/dL	Detects modest glycemic effect
Systolic/diastolic blood pressure	< 120/80 mmHg	Captures any vascular-relaxation effect

Cadence: Baseline, then at roughly 12 weeks, then every 6–12 months.

Qualitative Assessment

Energy levels and general sense of vitality
Exercise tolerance and perceived circulation (e.g., cold hands and feet)
Absence of digestive discomfort indicating good tolerability

Cordiart for Health & Longevity

Protocol

Benefits

Risk & Side Effects

Monitoring

Qualitative Assessment